
The U.S. Centers for Disease Control and Prevention on Thursday backed the emergency approval of Pfizer’s booster shots for Americans aged 16 and 17. The decision came shortly after the U.S. Food and Drug Administration authorized a third dose for that age group; boosters for those aged 18 and up were approved in November. “Although… read on > read on >